These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 53595)

  • 1. Letter: Transfer factor in Hodgkin's disease.
    Thornes RD; Braeman J; Bell JN; Browne O
    Lancet; 1975 Nov; 2(7944):1101. PubMed ID: 53595
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.
    Khan A; Hill JM; MacLellan A; Loeb E; Hill NO; Thaxton S
    Cancer; 1975 Jul; 36(1):86-9. PubMed ID: 1081903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer factor in Hodgkin's disease.
    Ng RP; Moran CJ; Alexopoulos CG; Bellingham AJ
    Lancet; 1975 Nov; 2(7941):901-3. PubMed ID: 53376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspecific transfer factor in children with Hodgkin's disease.
    Pasino M; Vadalà CR; Tonini GP; Comelli A; Perutelli P
    Boll Ist Sieroter Milan; 1976; 55(2):168-73. PubMed ID: 1088071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer factor in Hodgkin's disease: a randomized clinical and immunological study.
    Hancock BW; Bruce L; Sokol RJ; Clark A
    Eur J Cancer Clin Oncol; 1988 May; 24(5):929-33. PubMed ID: 3049116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: T and B lymphocytes in spleens in Hodgkin's disease.
    Wagener DJ; Geestman E; Borgonjen A
    Lancet; 1975 Jun; 1(7921):1378. PubMed ID: 48962
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: T and B lymphocytes in spleen in Hodgkin's disease.
    Joseph RR; Belpomme D
    Lancet; 1975 Mar; 1(7909):747-8. PubMed ID: 47511
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Lymphocytes in spleen in Hodgkin's disease.
    Grifoni V; Del Giacco GS; Manconi PE; Tognella S; Mantovani G
    Lancet; 1975 Feb; 1(7902):332-3. PubMed ID: 46472
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
    Khan A; Thometz D; Garrison O; Hill JM
    Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: IgM receptors on cells in Hodgkin's disease.
    Habeshaw JA; Stuart AE; Dewar AE; Young G
    Lancet; 1976 Apr; 1(7965):916. PubMed ID: 58187
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's disease.
    Verhaegen H; De Cock W; De Cree J; Verbruggen F; Verhaegen-Declercq M; Brugmans J
    Lancet; 1975 Apr; 1(7913):978. PubMed ID: 48151
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease.
    Biniaminov M; Ramot B
    Lancet; 1975 Feb; 1(7904):464. PubMed ID: 48661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of B and T lymphocytes in the peripheral blood of patients with Hodgkin's disease.
    Many A; Biniaminov M; Rosenthal E; Aghai E; Ramot B
    Acta Haematol; 1976; 56(1):1-6. PubMed ID: 822670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of T-lymphocyte subpopulations in Hodgkin's disease before and after chemotherapy.
    Nadkarni LS; Nadkarni JS; Kurkure PA; Shetty PA
    Indian J Cancer; 1986 Mar; 23(1):69-74. PubMed ID: 2950047
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of correlation between skin reactivity and T lymphocytes and monocytes in Hodgkin's disease.
    Müftüoğlu AU; Yalçin B
    Acta Haematol; 1980; 63(5):286-8. PubMed ID: 6774558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
    J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monocytes in Hodgkin's disease. I. Peripheral blood monocyte count in patients with advanced stages of Hodgkin's disease treated by polychemotherapy and radiotherapy in comparison with a total number of lymphocytes and T lymphocytes].
    Sciborski R
    Pol Arch Med Wewn; 1986 Feb; 75(2):135-41. PubMed ID: 3489225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.